Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan vs Hydrochlorothiazide in High Sodium Intake Hypertension
NCT02255253Completed
- Sponsor
- The George Institute for Global Health
- Start
- Oct 2014
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of telmisartan and hydrochlorothiazide in hypertension (HTN), sponsored by The George Institute for Global Health. Primary endpoint: Systolic Blood Pressure change at 2 months. Started Oct 2014; status: completed.
02
Drugs
telmisartanhydrochlorothiazide
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02255253.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02255253.